SI-BONE up as FDA clears device for pelvic procedures
** Shares of medical device co SI-BONE SIBN.O rise 2.7% to
$14.76
** Co receives U.S. FDA clearance for its iFuse Bedrock
Granite Implant system (https://refini.tv/3x1IySs)
** The device is used for fixation and fusion of sacroiliac
joints, which link the pelvis and lower spine
** Stock down ~33.54% YTD
(Reporting by Mrinalika Roy in Bengaluru)
((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))
Recent news on SI-BONE
See all newsBrief: SI-BONE Enters Fourth Amendment To Lease On Sept 11, 2026 - SEC Filing
SI-BONE Inc reports results for the quarter ended June 30 - Earnings Summary
SI-BONE Q2 revenue beats estimates, raises 2026 revenue outlook
Brief: SI-BONE Q2 Revenue USD 56.01 Million Vs. IBES Estimate USD 55.3 Million
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis